Carolin Schmelas

419 total citations
7 papers, 255 citations indexed

About

Carolin Schmelas is a scholar working on Molecular Biology, Infectious Diseases and Cellular and Molecular Neuroscience. According to data from OpenAlex, Carolin Schmelas has authored 7 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 1 paper in Infectious Diseases and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Carolin Schmelas's work include CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (2 papers) and Cancer therapeutics and mechanisms (1 paper). Carolin Schmelas is often cited by papers focused on CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (2 papers) and Cancer therapeutics and mechanisms (1 paper). Carolin Schmelas collaborates with scholars based in Germany, Switzerland and United States. Carolin Schmelas's co-authors include Dirk Grimm, Roland Eils, Mareike D. Hoffmann, Dominik Niopek, Felix Bubeck, Sabine Aschenbrenner, Bruno E. Correia, Zander Harteveld, Kathleen Börner and Laura Dietz and has published in prestigious journals such as Nature Methods, Nature Chemical Biology and Biotechnology Journal.

In The Last Decade

Carolin Schmelas

7 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carolin Schmelas Germany	7	227	34	28	27	27	7	255
Zander Harteveld Switzerland	6	221 1.0×	44 1.3×	18 0.6×	29 1.1×	30 1.1×	7	236
Felix Bubeck Germany	4	184 0.8×	47 1.4×	15 0.5×	23 0.9×	31 1.1×	7	205
Sabine Aschenbrenner Germany	7	381 1.7×	46 1.4×	41 1.5×	63 2.3×	45 1.7×	12	418
Ruirui Sun China	9	260 1.1×	6 0.2×	21 0.8×	14 0.5×	8 0.3×	14	298
Benjamin M. Heineike United States	7	244 1.1×	9 0.3×	34 1.2×	10 0.4×	13 0.5×	9	291
Muhammad N. Ramli Singapore	3	195 0.9×	6 0.2×	25 0.9×	20 0.7×	17 0.6×	4	205
Emma Tysinger United States	4	198 0.9×	4 0.1×	50 1.8×	20 0.7×	22 0.8×	5	219
Lukas Schmidheini Switzerland	8	301 1.3×	6 0.2×	109 3.9×	23 0.9×	20 0.7×	9	327
Birong Cao China	4	239 1.1×	14 0.4×	34 1.2×	17 0.6×	13 0.5×	5	265

Countries citing papers authored by Carolin Schmelas

Since Specialization

Citations

This map shows the geographic impact of Carolin Schmelas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolin Schmelas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolin Schmelas more than expected).

Fields of papers citing papers by Carolin Schmelas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolin Schmelas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolin Schmelas. The network helps show where Carolin Schmelas may publish in the future.

Co-authorship network of co-authors of Carolin Schmelas

This figure shows the co-authorship network connecting the top 25 collaborators of Carolin Schmelas. A scholar is included among the top collaborators of Carolin Schmelas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolin Schmelas. Carolin Schmelas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Schmelas, Carolin, et al.. (2023). Overcoming MET-mediated resistance in oncogene-driven NSCLC. iScience. 26(7). 107006–107006. 6 indexed citations

2.

Freistaedter, Andrew, et al.. (2021). An RNA Interference/Adeno‐Associated Virus Vector–Based Combinatorial Gene Therapy Approach Against Hepatitis E Virus. Hepatology Communications. 6(4). 878–888. 13 indexed citations

3.

Harteveld, Zander, Carolin Schmelas, Julius Upmeier zu Belzen, et al.. (2020). Computational design of anti-CRISPR proteins with improved inhibition potency. Nature Chemical Biology. 16(7). 725–730. 15 indexed citations

4.

Belzen, Julius Upmeier zu, Felix Bubeck, Moritz J. Przybilla, et al.. (2019). Leveraging implicit knowledge in neural networks for functional dissection and engineering of proteins. Nature Machine Intelligence. 1(5). 225–235. 19 indexed citations

5.

Bubeck, Felix, Mareike D. Hoffmann, Zander Harteveld, et al.. (2018). Engineered anti-CRISPR proteins for optogenetic control of CRISPR–Cas9. Nature Methods. 15(11). 924–927. 158 indexed citations

6.

Schmelas, Carolin & Dirk Grimm. (2018). Split Cas9, Not Hairs − Advancing the Therapeutic Index of CRISPR Technology. Biotechnology Journal. 13(9). e1700432–e1700432. 24 indexed citations

7.

Ahlmann-Eltze, Constantin, Jan Gleixner, Carolin Schmelas, et al.. (2015). Backbone circularization of Bacillus subtilis family 11 xylanase increases its thermostability and its resistance against aggregation. Molecular BioSystems. 11(12). 3231–3243. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact